Brief: Sakar Healthcare Gets WHO GMP Approval For Oncology Injection Unit
05/07/2023 06:07
July 5 (Reuters) - Sakar Healthcare Ltd SAKA.NS :
* SAKAR HEALTHCARE LTD - WHO GMP APPROVAL RECEIVED FOR
ONCOLOGY
INJECTION UNIT AT VERTICALLY INTEGRATED ONCOLOGY PRODUCT
MANUFACTURING SITE
Source text for Eikon: ID:nNSE1YyZ5y
Further company coverage: SAKA.NS
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Sakar Healthcare
See all newsIndia's Sakar Healthcare jumps on regulatory approvals for cancer drugs
Brief: Sakar Healthcare Gets 14 Oncology Product New Approvals In EU, UK, Canada With 7 Business Partners
Brief: Sakar Healthcare Says Co Added To Manufacturing Of Accord's (UK) Finished Product Imatinib Accord
Australia's Algorae Pharmaceuticals rises on licensing deal with Sakar Healthcare
Brief: Algorae Pharmaceuticals Signs Exclusive License Agreement With Sakar